Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation.

Pérez-Andújar A, Newhauser WD, Taddei PJ, Mahajan A, Howell RM.

Phys Med Biol. 2013 May 21;58(10):3107-23. doi: 10.1088/0031-9155/58/10/3107. Epub 2013 Apr 19.

2.

Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.

Zhang R, Howell RM, Giebeler A, Taddei PJ, Mahajan A, Newhauser WD.

Phys Med Biol. 2013 Feb 21;58(4):807-23. doi: 10.1088/0031-9155/58/4/807. Epub 2013 Jan 16.

3.

Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?

Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, Maor MH, Woo SY, Cox JD, Smith AR.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):362-72.

PMID:
16168831
4.

Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.

Min CH, Paganetti H, Winey BA, Adams J, MacDonald SM, Tarbell NJ, Yock TI.

Radiat Oncol. 2014 Nov 18;9:220. doi: 10.1186/s13014-014-0220-8.

5.

Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: minimizing the life years lost attributable to failure to control the disease and late complication risk.

Brodin NP, Vogelius IR, Björk-Eriksson T, Munck Af Rosenschöld P, Maraldo MV, Aznar MC, Specht L, Bentzen SM.

Acta Oncol. 2014 Apr;53(4):462-70. doi: 10.3109/0284186X.2013.858824. Epub 2013 Nov 25.

PMID:
24274390
6.

A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.

Zhang R, Howell RM, Taddei PJ, Giebeler A, Mahajan A, Newhauser WD.

Radiother Oncol. 2014 Oct;113(1):84-8. doi: 10.1016/j.radonc.2014.07.003. Epub 2014 Aug 12.

7.
8.

Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.

Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1173-80. doi: 10.1016/j.ijrobp.2008.12.048. Epub 2009 Apr 20.

PMID:
19386423
9.

Late toxicity following craniospinal radiation for early-stage medulloblastoma.

Christopherson KM, Rotondo RL, Bradley JA, Pincus DW, Wynn TT, Fort JA, Morris CG, Mendenhall NP, Marcus RB Jr, Indelicato DJ.

Acta Oncol. 2014 Apr;53(4):471-80. doi: 10.3109/0284186X.2013.862596. Epub 2014 Feb 24.

PMID:
24564687
10.

Optimization of Craniospinal Irradiation for Pediatric Medulloblastoma Using VMAT and IMRT.

Al-Wassia RK, Ghassal NM, Naga A, Awad NA, Bahadur YA, Constantinescu C.

J Pediatr Hematol Oncol. 2015 Oct;37(7):e405-11. doi: 10.1097/MPH.0000000000000418.

PMID:
26334433
11.

Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.

Eaton BR, Esiashvili N, Kim S, Patterson B, Weyman EA, Thornton LT, Mazewski C, MacDonald TJ, Ebb D, MacDonald SM, Tarbell NJ, Yock TI.

Neuro Oncol. 2016 Jun;18(6):881-7. doi: 10.1093/neuonc/nov302. Epub 2015 Dec 19.

12.

Life years lost--comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale.

Brodin NP, Vogelius IR, Maraldo MV, Munck af Rosenschöld P, Aznar MC, Kiil-Berthelsen A, Nilsson P, Björk-Eriksson T, Specht L, Bentzen SM.

Cancer. 2012 Nov 1;118(21):5432-40. doi: 10.1002/cncr.27536. Epub 2012 Apr 19.

13.

The risk of developing a second cancer after receiving craniospinal proton irradiation.

Newhauser WD, Fontenot JD, Mahajan A, Kornguth D, Stovall M, Zheng Y, Taddei PJ, Mirkovic D, Mohan R, Cox JD, Woo S.

Phys Med Biol. 2009 Apr 21;54(8):2277-91. doi: 10.1088/0031-9155/54/8/002. Epub 2009 Mar 20.

14.

A method for reducing ovarian doses in whole neuro-axis irradiation for medulloblastoma.

Harden SV, Twyman N, Lomas DJ, Williams D, Burnet NG, Williams MV.

Radiother Oncol. 2003 Nov;69(2):183-8.

PMID:
14643956
15.

Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.

Boehling NS, Grosshans DR, Bluett JB, Palmer MT, Song X, Amos RA, Sahoo N, Meyer JJ, Mahajan A, Woo SY.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):643-52. doi: 10.1016/j.ijrobp.2010.11.027. Epub 2011 Jan 27.

PMID:
21277111
16.

Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.

Paganetti H, Athar BS, Moteabbed M, A Adams J, Schneider U, Yock TI.

Phys Med Biol. 2012 Oct 7;57(19):6047-61. doi: 10.1088/0031-9155/57/19/6047. Epub 2012 Sep 12.

PMID:
22968191
17.

Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.

Merchant TE, Schreiber JE, Wu S, Lukose R, Xiong X, Gajjar A.

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):554-61. doi: 10.1016/j.ijrobp.2014.06.058. Epub 2014 Aug 23.

18.

Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.

Cox MC, Kusters JM, Gidding CE, Schieving JH, van Lindert EJ, Kaanders JH, Janssens GO.

Radiat Oncol. 2015 Nov 24;10:241. doi: 10.1186/s13014-015-0547-9.

19.

Comparison of a new noncoplanar intensity-modulated radiation therapy technique for craniospinal irradiation with 3 coplanar techniques.

Hansen AT, Lukacova S, Lassen-Ramshad Y, Petersen JB.

Med Dosim. 2015 Winter;40(4):296-303. doi: 10.1016/j.meddos.2015.03.007. Epub 2015 May 19.

PMID:
26002123
20.

Technique for sparing previously irradiated critical normal structures in salvage proton craniospinal irradiation.

McDonald MW, Wolanski MR, Simmons JW, Buchsbaum JC.

Radiat Oncol. 2013 Jan 12;8:14. doi: 10.1186/1748-717X-8-14.

Supplemental Content

Support Center